Apotex president and CEO steps down amid allegations of trade secret leaks


Apotex Inc. president and CEO Jeremy Desai resigned effective immediately Friday from the generic drug giant founded by the recently deceased billionaire Barry Sherman. Desai's resignation comes as he faces allegations in a U.S. lawsuit from Teva Pharmaceutical Industries Ltd. for allegedly accepting trade secrets from a Teva employee that he was thought to be in a romantic relationship with.



from Biotech News